Stocks Health care GHRS
NASDAQ · Health careGH Research PLC (GHRS)
It posted a net loss of $48.3M. In fiscal 2025 capital spending exceeded operating cash flow by $43.7M. At December 31, 2025 it held $246.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
What GH Research PLC does
GH Research PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GHRS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$48.3M | -$0.79 | -$43.7M |
| 2024 | n/a | -$39M | -$0.75 | -$42.3M |
| 2023 | n/a | -$35.6M | -$0.68 | -$33.4M |
| 2022 | n/a | -$22.5M | -$0.43 | -$26.3M |
| 2021 | n/a | -$9.2M | -$0.21 | -$15.4M |
| 2021 | n/a | -$446K | -$0.02 | -$330K |
Latest SEC filings
What GH Research PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 11, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026
- June 26, 2026
- June 4, 2026
- May 21, 2026
- May 18, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 14, 2026
Questions about GHRS
What does GH Research PLC do?
GH Research PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GHRS.
Is GH Research PLC profitable?
No. In fiscal 2025 it reported a net loss of $48.3M.
When did GH Research PLC last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 11, 2026.
Similar companies
Follow GHRS
Get an email when GH Research PLC files with the SEC: results, executive changes, material agreements and annual reports.
Follow GHRS: get an email when it filesWhere the numbers come from
Financial figures are the values GH Research PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.